Acorah Software Products - Accounts Production 19.3.550 false true 31 October 2024 1 November 2023 false 1 November 2024 31 October 2025 31 October 2025 12265479 Mr K Ukho Mr I Sydorenko Mrs W B Nowakowska Mr O Honchar Mr D Dmytrenko iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12265479 2024-10-31 12265479 2025-10-31 12265479 2024-11-01 2025-10-31 12265479 frs-core:CurrentFinancialInstruments 2025-10-31 12265479 frs-core:SharePremium 2025-10-31 12265479 frs-core:ShareCapital 2025-10-31 12265479 frs-core:RetainedEarningsAccumulatedLosses 2025-10-31 12265479 frs-bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 12265479 frs-bus:FilletedAccounts 2024-11-01 2025-10-31 12265479 frs-bus:SmallEntities 2024-11-01 2025-10-31 12265479 frs-bus:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 12265479 frs-bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 12265479 frs-bus:Director1 2024-11-01 2025-10-31 12265479 frs-bus:Director2 2024-11-01 2025-10-31 12265479 frs-bus:Director3 2024-11-01 2025-10-31 12265479 frs-bus:Director4 2024-11-01 2025-10-31 12265479 frs-bus:Director5 2024-11-01 2025-10-31 12265479 frs-countries:EnglandWales 2024-11-01 2025-10-31 12265479 2023-10-31 12265479 2024-10-31 12265479 2023-11-01 2024-10-31 12265479 frs-core:CurrentFinancialInstruments 2024-10-31 12265479 frs-core:SharePremium 2024-10-31 12265479 frs-core:ShareCapital 2024-10-31 12265479 frs-core:RetainedEarningsAccumulatedLosses 2024-10-31
Registered number: 12265479
Neurons Lab Ltd
Unaudited Financial Statements
For The Year Ended 31 October 2025
Peter Jarman LLP
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2—3
Page 1
Balance Sheet
Registered number: 12265479
2025 2024
Notes £ £ £ £
CURRENT ASSETS
Debtors 4 182,295 118,833
Investments 5 29,627 -
Cash at bank and in hand 228,360 376,519
440,282 495,352
Creditors: Amounts Falling Due Within One Year 6 (181,737 ) (150,354 )
NET CURRENT ASSETS (LIABILITIES) 258,545 344,998
TOTAL ASSETS LESS CURRENT LIABILITIES 258,545 344,998
NET ASSETS 258,545 344,998
CAPITAL AND RESERVES
Called up share capital 7 10,657 10,657
Share premium account 307,691 307,691
Profit and Loss Account (59,803 ) 26,650
SHAREHOLDERS' FUNDS 258,545 344,998
For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mrs W B Nowakowska
Director
30/07/2026
The notes on pages 2 to 3 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
Neurons Lab Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 12265479 . The registered office is International House, 64 Nile Street, London, N1 7SR.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
2.3. Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. 
Current or deferred taxation assets and liabilities are not discounted. 
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. 
Deferred Tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. 
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. 
Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. 
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. 
3. Average Number of Employees
Average number of employees, including directors, during the year was: 5 (2024: 5)
5 5
4. Debtors
2025 2024
£ £
Due within one year
Trade debtors 140,589 42,844
Other debtors 41,706 75,989
182,295 118,833
5. Current Asset Investments
2025 2024
£ £
Shares in subsidiaries 29,627 -
Page 2
Page 3
6. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Trade creditors 124,158 144,013
Amounts owed to group undertakings 23,862 -
Other creditors 33,717 6,341
181,737 150,354
7. Share Capital
2025 2024
£ £
Allotted, Called up and fully paid 10,657 10,657
Page 3